Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases

Denosumab has been used successfully to treat disease‐associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias including central giant cell granuloma (CGCG), aneurysmal bone cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Upfill‐Brown, Alexander, Bukata, Susan, Bernthal, Nicholas M, Felsenfeld, Alan L, Nelson, Scott D, Singh, Arun, Wesseling‐Perry, Katherine, Eilber, Fritz C, Federman, Noah C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820455/
https://www.ncbi.nlm.nih.gov/pubmed/31687646
http://dx.doi.org/10.1002/jbm4.10210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820455/
https://www.ncbi.nlm.nih.gov/pubmed/31687646
http://dx.doi.org/10.1002/jbm4.10210

Ejemplares similares